ALLG APML5: a comparative bioavailability study of encapsulated oral arsenic trioxide and intravenous arsenic trioxide in patients with acute promyelocytic leukemia undergoing consolidation therapy

H. Iland, J. Reynolds, A. Boddy, L. Khoo, S. Yuen, R. Gasiorowski, S. Lane, A. Wei, R. Harrup, P. Marlton, C. Risteski

Research output: Contribution to journal › Meeting abstract › peer-review

Fingerprint

Dive into the research topics of 'ALLG APML5: a comparative bioavailability study of encapsulated oral arsenic trioxide and intravenous arsenic trioxide in patients with acute promyelocytic leukemia undergoing consolidation therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences